Who
ALAFI CAPITAL CO LLC
10% owner
Company insider
Files Form 4 as: 10% owner, CalciMedica; 10% owner, Intra-Cellular Therapies; 10% owner, Stereotaxis.
In numbers
- Trades disclosed
- 19
- Buys
- 13
- Sells
- 0
- Bought
- $6.5M
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 15 Nov 2006
- Last trade
- 19 Aug 2026
- Last filed
- 24 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 Aug 2026filed 24 Aug 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,529,192 at $0.00 | filing |
| 19 Aug 2026filed 24 Aug 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,529,192 at $0.00 | filing |
| 19 Aug 2026filed 24 Aug 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,529,192 at $0.00 | filing |
| 19 Aug 2026filed 24 Aug 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,529,192 at $0.00 | filing |
| 2 Oct 2017filed 3 Oct 2017 | Intra-Cellular Therapies | SEC FORM 4 Bought | $4.0M258,065 at $15.50 | filing |
| 7 Dec 2016filed 7 Dec 2016 | Intra-Cellular Therapies | SEC FORM 4 Bought | $336K20,826 at $16.14 | filing |
| 6 Dec 2016filed 7 Dec 2016 | Intra-Cellular Therapies | SEC FORM 4 Bought | $721K44,174 at $16.33 | filing |
| 14 Nov 2016filed 17 Nov 2016 | Intra-Cellular Therapies | SEC FORM 4 Bought | $493K34,000 at $14.50 | filing |
| 1 Dec 2014filed 3 Dec 2014 | Intra-Cellular Therapies | SEC FORM 4 Bought | $21K1,422 at $14.75 | filing |
| 28 Nov 2014filed 28 Nov 2014 | Intra-Cellular Therapies | SEC FORM 4 Bought | $516K35,000 at $14.75 | filing |
| 19 Nov 2014filed 21 Nov 2014 | Intra-Cellular Therapies | SEC FORM 4 Bought | $15K1,034 at $14.25 | filing |
| 18 Nov 2014filed 18 Nov 2014 | Intra-Cellular Therapies | SEC FORM 4 Bought | $50K3,531 at $14.23 | filing |
| 14 Nov 2014filed 18 Nov 2014 | Intra-Cellular Therapies | SEC FORM 4 Bought | $2,004133 at $15.07 | filing |
| 13 Nov 2014filed 13 Nov 2014 | Intra-Cellular Therapies | SEC FORM 4 Bought | $33K2,200 at $15.12 | filing |
| 12 Nov 2014filed 13 Nov 2014 | Intra-Cellular Therapies | SEC FORM 4 Bought | $76K5,000 at $15.23 | filing |
| 11 Nov 2014filed 13 Nov 2014 | Intra-Cellular Therapies | SEC FORM 4 Bought | $78K5,000 at $15.55 | filing |
| 15 Mar 2007filed 19 Mar 2007 | STXS StereotaxisMedical Devices | SEC FORM 4 Bought | $109K10,000 at $10.89 | filing |
| 15 Nov 2006filed 17 Nov 2006 | STXS Stereotaxisoption or derivative · Medical Devices | SEC FORM 4 Code X | —76,804 at $0.00 | filing |
| 15 Nov 2006filed 17 Nov 2006 | STXS StereotaxisMedical Devices | SEC FORM 4 Code X | $600K76,804 at $7.81 | filing |
News
No headline names them, or the companies they trade most, lately.